Beyond the Lab: Modernizing the Pharma Value Chain with Cloudera + AWS

Date:

The race to deliver life-saving therapies is currently hindered by fragmented data and skyrocketing R&D costs. To win, data leaders must bridge the gap between massive data growth and meaningful clinical insights.

In this session, Cloudera and AWS reveal the blueprint for a high-performance data lakehouse designed specifically for the pharmaceutical industry. Learn how to leverage advanced analytics to slash time-to-market and ensure your organization is AI-ready.

What You’ll Learn:

  • Scale with Confidence: Deploying AI/ML across the enterprise without compromising security or governance.
  • Efficiency at Every Step: How unified data reduces the friction between drug discovery and commercialization.
  • Future-Proofing Infrastructure: Building a hybrid architecture that adapts to the evolving life sciences landscape.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

RISK MANAGEMENT FROM RISK CONTROL TO GROWTH ENGINE

As organisations navigate an increasingly complex landscape shaped by...

60% of AU and SG brands missed their moment last year.

Klaviyo surveyed 400+ B2C marketers across Australia and Singapore...

AI hasn’t created “the AI shopper.” It’s created four.

Most brands are making a costly assumption: that their...

What is discounting actually costing ANZ brands?

ew research from marketing effectiveness expert James Hurman across...